Drug profile · INN
oxaprozin
DAYPRO
oxaprozin (DAYPRO) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — oxaprozin
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
oxaprozin (DAYPRO) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is oxaprozin?
oxaprozin (DAYPRO) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oxaprozin?
DAYPRO is a marketed brand name for oxaprozin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxaprozin?
oxaprozin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.